Europe Enteral Nutrition Market 2020-2030

Europe enteral nutrition market was valued at $2,168.9 million in 2020 and will grow by 8.6% annually over 2020-2030 owing to the increasing incidence of malnutrition, rising number of patients suffering with chronic diseases, and surge in adoption of enteral nutrition over parenteral nutrition due to lower cost and complications of enteral nutrition. In addition, according to the Europe 2021 Aging Report, 21% of the Europe population was aged 65 years or above and this number is projected to increase by 14% by 2100. Thus, the increasing number of the geriatric population who are more prone to develop metabolic disorders is likely to increase the demand for nutrition therapy to prevent acute complications, such as metabolic decompensation, and/or to prevent long-term complications of the given disorder, which is expected to augment the market growth over the forecast period.

Furthermore, the increasing government initiatives in launching guidelines and aware people regarding Enteral Nutrition are also contributing to the growth of the market. For instance, in June 2020, the European Society for Enteral Nutrition and Management launched its guideline on Enteral Nutrition in inflammatory bowel disease (IBD) as an app version for smartphones and tablets for professionals (physicians, nurses, dieticians, nutritionists, etc).However, the unwillingness of hospitals and in-house pharmacies/ dispensaries to maintain the required stock of Enteral Nutrition products and imprecise perception about Enteral Nutrition are likely to restrain the market growth over the forecast period.The nutritional support for the metabolic disorders segment is expected to witness significant growth over the forecast period owing to the factors such as the rising prevalence of metabolic disorders such as diabetes, liver diseases, cardiovascular diseases, and others among the population. For instance, according to International Diabetes Federation Atlas 2021 Fact Sheet, it has been found that 61 million adults have diabetes in the region and 36% of the adults living with diabetes are undiagnosed. As per the same source, the prevalence of diabetes in the population aged between 20 years to 79 years was 9.2% in 2021 and it is projected that the prevalence rate will increase to 9.8% in 2030 and 10.4% in 2045. Thus, the increasing burden of diabetes among the population is expected to increase the demand for nutrition therapy to control blood sugar (glucose), manage weight to reduce heart-related risks such as high blood pressure and high blood fats, which is expected to augment the market growth over the forecast period.In addition, the rising geriatric population in the region is also contributing to the growth of the market. For instance, as per Germany Federal Statistical Office 2020 report, currently, there is about 83 million population in Germany out of which 16.2 million population are above 67 years of age, and this number is projected to reach 21.4 million in 2040. The number of elderly population is expected to increase in the near future who are more prone to metabolic, neurological, and other disorders, which is expected to increase the demand for nutrition therapy, thereby propelling the market growth over the forecast period.

Thus, the increasing burden of metabolic disorders, growing geriatric population, and rising company activities in the region are expected to increase the demand for Enteral Nutrition therapy and products to reduce the risks of developing chronic diseases, which is expected to augment the market growth over the forecast period. The Europe Enteral Nutrition market is consolidated and competitive and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. Factors such as the increasing prevalence of metabolic diseases the market is expected to grow furthermore. Hence, few other players are expected to penetrate the market in the coming years.

Recent Development

In April 2022, Glanbia Nutritionals launched TechVantage at the nutraceutical event Vitafoods Europe. TechVantage will provide customers with nutrient solutions with stability enhancements, the ability to mask flavors/colors, and solubility/flowability improvements.

In January 2022, World Health Organization/Europe launched a new, voluntary, Member State-led Sugar and Calorie Reduction Network to promote healthier diets as well as reduce overweight and obesity levels across the World Health Organization European Region.

COVID-19 Impact
The market was moderately impacted by the COVID-19 pandemic, with the medical sector focusing on dealing with the virus attention towards this sector was compromised and patients seeking recovery could not achieve so. With this the disruption of the supply chain and the stopping of production activities across the region due to Lockdowns further created a negative impact.

Highlighted with 37 tables and 56 figures, this 119-page report “Europe Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country.

Based on Nutrient, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Protein Based Nutrition
• Standard Protein Diet
• High Protein Supplement
• Protein for Diabetic Patients
• Other Protein-based Nutitions
• Carbohydrates Based Nutrition
• Fat Based Nutrition
• Vitamin Based Nutrition
• Other Nutrition Types

Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Critical Care
• Diabetes
• Neurology
• Oncology
• Other Applications

Based on Category, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Enteral Nutrition for Chronic Illness
• Enteral Nutrition with Standard Formula

Based on Product Form, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Liquid Enteral Nutrition
• Powder Enteral Nutrition

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pediatric
• Adults
• Geriatric

Based on Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Distribution by Hospitals
• Distribution by Retail Pharmacies
• Distribution by Online Pharmacies

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Nutrient, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
B. Braun Melsungen AG
Baxter International, Inc.
Danone S.A.
Fresenius Kabi AG
Europe Health Products, Inc.
Hormel Foods Corporation
Meiji Holdings Co., Ltd.
Nestle S.A.
Reckitt Benckiser (Mead Johnson & Company LLC)
Victus, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now